Laryngo-pharyngeal Reflux
37
2
3
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
8.1%
3 terminated out of 37 trials
83.3%
-3.2% vs benchmark
27%
10 trials in Phase 3/4
40%
6 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 15 completed trials
Clinical Trials (37)
Effect of Topical Anesthesia on the Phonation Process During High-Speed Digital Imaging Laryngoscopy in Patients With Laryngopharyngeal Reflux
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux
European TIF2.0 Registry
Comprehensive Analysis of the Swallowing Mechanism Using High-resolution Manometry With Impedance
The Johns Hopkins Heartburn Center Registry
The Mechanism Versus PPI Trial
Reflux Band in Laryngopharyngeal Reflux
Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction
Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD
Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough
Method of Early Diagnosis of Laryngopharyngeal Reflux
LPR Fluorescence Pilot
Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis
CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions
Efficacy of Reza Band for the Treatment of Laryngopharyngeal Reflux
Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin
The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux